Atypical hemolytic uremic syndrome with complement gene abnormality Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

1Recruiting trials

Regulatory Watchboard

1 event

Feb 2024Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

Mario Negri Institute for Pharmacological Research — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Atypical hemolytic uremic syndrome with complement gene abnormality.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

CARBAMAZEPINE

(CARBAMAZEPINE)standard

Alembic Pharmaceuticals Inc.

Mood Stabilizer [EPC]

Mechanism of Action Carbamazepine has demonstrated anticonvulsant properties in rats and mice with electrically and chemically induced seizures. It ap...

FDA label ↗

View full treatment details on disease page →